Company intelligence / Profile preview

TinkerBio

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

TinkerBio is a Chinese high‑tech enterprise founded in 2014 that develops and manufactures microfluidic chips, including centrifugal microfluidic chips used in molecular diagnostics such as SARS‑CoV‑2 nucleic acid detection; it acts as a technology and production platform supplier rather than a therapeutic/drug pipeline company.

Modalities: DeviceMicrofluidic platform
Industry: Molecular Diagnostics

Partnerships

Supplies centrifugal microfluidic chips/equipment such as the TBS‑200 vacuum hot‑pressing machine and chips used by academic and clinical research groups for SARS‑CoV‑2 detection assays.

Beyond the preview

Go deeper on TinkerBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TinkerBio.

Explore the full profile